Sign Up to like & get
recommendations!
1
Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox12010015
Abstract: Inflammation, oxidative stress, and apoptosis are thought to be important causes of chronic obstructive pulmonary disease (COPD). We investigated the effect of YPL-001 (under phase 2a study, ClinicalTrials.gov identifier NCT02272634), a drug derived from Pseudolysimachion…
read more here.
Keywords:
cigarette smoke;
activity;
cse induced;
ypl 001 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24087229
Abstract: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease which causes breathing problems. YPL-001, consisting of six iridoids, has potent inhibitory efficacy against COPD. Although YPL-001 has completed clinical trial phase 2a as…
read more here.
Keywords:
inflammation;
pkc activation;
lung;
ypl 001 ... See more keywords